Response to Windahl et al.

Journal of Clinical Investigation

Volumn 116, Issue 11, 2006, Pages 2834-

  Manolagas, Stavros C ^a,b   Jilka, Robert L ^a   Kousteni, Stavroula ^a   Bellido, Teresita ^a   Weinstein, Robert S ^a   O'Brien, Charles A ^a   Plotkin, Lilian ^a   Han, Li ^a  

^a UNIVERSITY OF ARKANSAS FOR MEDICAL SCIENCES   (United States)

^b NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANDROGEN RECEPTOR; DIETHYLSTILBESTROL; ESTRADIOL;

CELL DIFFERENTIATION; HORMONE SUBSTITUTION; LETTER; NONHUMAN; OSTEOCLAST; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; PRIORITY JOURNAL; UTERUS GROWTH;

ANIMALS; ESTRADIOL; FEMALE; HUMANS; MICE; OSTEOPOROSIS, POSTMENOPAUSAL; SIGNAL TRANSDUCTION;

EID: 33750589516     PISSN: 00219738     EISSN: 15588238     Source Type: Journal    
DOI: 10.1172/JCI30535     Document Type: Letter

References (9)

1. Windahl, S.H., et al. 2006. Bone protection by estrens occurs through non-tissue-selective activation of the androgen receptor. J. Clin. Invest. 116:2500-2509. doi:10.1172/JCI28809.
2. Kousteni, S., et al. 2002. Reversal of bone loss in mice by nongenotropic signaling of sex steroids. Science. 298:843-846.
3. Weinstein, R.S., et al. 2004. The skeletal effects of glucocorticoid excess override those of orchidectomy in mice. Endocrinology. 145:1980-1987.
4. Modder, U.I., et al. 2004. Dose-response of estrogen on bone versus the uterus in ovariectomized mice. Eur. J. Endocrinol. 151:503-510.
5. Hewitt, S.C., Collins, J., Grissom, S., Hamilton, K., and Korach, K.S. 2006. Estren behaves as a weak estrogen rather than a nongenomic selective activator in the mouse uterus. Endocrinology. 147:2203-2214.
6. Moverare, S., et al. 2003. Estren is a selective estrogen receptor modulator with transcriptional activity. Mol. Pharmacol. 64:1428-1433.
7. Ettinger, B., et al. 2004. Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet. Gynecol. 104:443-451.
8. Galien, R., et al. 2004. Estrens protect bone against ovariectomy-induced bone loss in mice but fail to be selective on reproductive organs and/or breast cancer cell lines [abstract]. J. Bone Miner. Res. 19:S321.
9. Riggs, B.L., and Parfitt, A.M. 2005. Drugs used to treat osteoporosis: the critical need for a uniform nomenclature based on their action on bone remodeling. J. Bone Miner. Res. 20:177-184.